Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells
about
FOXM1, a typical proliferation-associated transcription factorCombination chemical geneticsForkhead box M1 transcription factor: a novel target for cancer therapy.FoxM1 is a novel target of a natural agent in pancreatic cancer.Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.Overexpression of activating transcription factor 5 in human rectal cancer.Capecitabine-docetaxel combination treatment.Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells.Neoadjuvant docetaxel and capecitabine in patients with high risk prostate cancer.Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. II. gamma-Tubulin.FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesisRegulation of stem cells-related signaling pathways in response to doxorubicin treatment in Hs578T triple-negative breast cancer cells.The Role of FoxC2 Transcription Factor in Tumor Angiogenesis.Gene expression profiling of the androgen independent prostate cancer cells demonstrates complex mechanisms mediating resistance to docetaxel.FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.Identification and immunotherapeutic targeting of antigens induced by chemotherapy.d -Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis.Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
P2860
Q28257808-8D7532F3-A475-4619-ACBA-F36E5FA04F08Q33378070-68515E50-282F-4B51-BAEB-368E12252FE1Q33729250-408246FC-36F3-41E3-9E36-8C24128275BBQ34286063-B904C33A-C5FC-4298-80DD-420217A4F442Q34993890-C8E96277-3812-4AF2-B158-D6F2F77C47BDQ36230721-631C9F04-9332-4C8B-88C9-B20D6D7B6750Q36613965-45DF83E9-F62C-46A4-AD64-1D08B0266D5DQ37220370-3C5CB92F-7E10-441B-B6ED-0F695A38E6EEQ37309238-842035CC-9F29-4704-B3A6-57AC39F070A7Q37570230-B22317DD-5408-49BF-9537-C6C2EF49AE97Q37716906-989BC459-00DA-4B4D-AB22-F9607045C60FQ38851695-A73A2D3F-1BC5-4EC7-ADAE-86CE9A3D5675Q39521033-8C111A62-C5E2-4CAF-B0EC-FD115608216FQ39589654-2683AC6E-60F0-4FC4-88EA-9211636E3121Q39790063-276DF06B-F423-4EDD-A219-E63815FDCDE8Q40323650-A3770BC5-DB04-43EA-B353-A8C1B6BDC180Q41292697-8F3B8EB8-1A0B-4782-A47B-8323A4DF3872Q41708911-C2CE5F3C-A77D-4A1D-AFFD-5434814C88BF
P2860
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gene expression profiling reve ...... tulon in prostate cancer cells
@ast
Gene expression profiling reve ...... tulon in prostate cancer cells
@en
Gene expression profiling reve ...... tulon in prostate cancer cells
@nl
type
label
Gene expression profiling reve ...... tulon in prostate cancer cells
@ast
Gene expression profiling reve ...... tulon in prostate cancer cells
@en
Gene expression profiling reve ...... tulon in prostate cancer cells
@nl
prefLabel
Gene expression profiling reve ...... tulon in prostate cancer cells
@ast
Gene expression profiling reve ...... tulon in prostate cancer cells
@en
Gene expression profiling reve ...... tulon in prostate cancer cells
@nl
P2093
P2860
P356
P1433
P1476
Gene expression profiling reve ...... tulon in prostate cancer cells
@en
P2093
Fazlul H Sarkar
James Eliason
Maha Hussain
Sarah H Sarkar
P2860
P2888
P356
10.1186/1471-2407-5-7
P407
P577
2005-01-18T00:00:00Z
P5875
P6179
1030772597